Henry Schein (NASDAQ:HSIC) Rating Increased to Buy at StockNews.com

Henry Schein (NASDAQ:HSICGet Rating) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday.

A number of other research firms have also recently weighed in on HSIC. Morgan Stanley decreased their price objective on Henry Schein from $72.00 to $70.00 and set an “underweight” rating for the company in a research report on Wednesday, December 21st. Piper Sandler dropped their price objective on shares of Henry Schein from $96.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, September 26th. Finally, William Blair reaffirmed a “market perform” rating on shares of Henry Schein in a report on Tuesday, November 1st. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $84.44.

Henry Schein Price Performance

HSIC stock opened at $80.86 on Thursday. The business has a 50 day simple moving average of $80.65 and a 200-day simple moving average of $75.60. The company has a market capitalization of $10.96 billion, a P/E ratio of 17.58, a PEG ratio of 2.15 and a beta of 0.82. Henry Schein has a twelve month low of $64.75 and a twelve month high of $92.68. The company has a current ratio of 1.84, a quick ratio of 1.00 and a debt-to-equity ratio of 0.22.

Henry Schein (NASDAQ:HSICGet Rating) last issued its quarterly earnings data on Tuesday, November 1st. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.01. Henry Schein had a net margin of 5.06% and a return on equity of 15.48%. The company had revenue of $3.07 billion for the quarter, compared to the consensus estimate of $3.22 billion. As a group, equities analysts anticipate that Henry Schein will post 4.81 EPS for the current year.

Insider Buying and Selling

In other Henry Schein news, CEO Stanley M. Bergman sold 54,216 shares of the company’s stock in a transaction on Monday, December 12th. The stock was sold at an average price of $81.16, for a total value of $4,400,170.56. Following the sale, the chief executive officer now owns 488,126 shares of the company’s stock, valued at $39,616,306.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Stanley M. Bergman sold 54,216 shares of Henry Schein stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $81.16, for a total transaction of $4,400,170.56. Following the completion of the transaction, the chief executive officer now owns 488,126 shares in the company, valued at $39,616,306.16. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Lorelei Mcglynn sold 15,341 shares of the stock in a transaction that occurred on Tuesday, December 20th. The shares were sold at an average price of $80.70, for a total transaction of $1,238,018.70. Following the completion of the sale, the senior vice president now owns 73,753 shares in the company, valued at $5,951,867.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 76,397 shares of company stock valued at $6,190,246. 1.00% of the stock is owned by insiders.

Institutional Trading of Henry Schein

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Massachusetts Financial Services Co. MA acquired a new position in Henry Schein in the 2nd quarter valued at about $159,204,000. FMR LLC raised its position in shares of Henry Schein by 189.6% in the second quarter. FMR LLC now owns 2,179,126 shares of the company’s stock valued at $167,226,000 after buying an additional 1,426,767 shares during the last quarter. Pendal Group Ltd lifted its stake in shares of Henry Schein by 26.0% during the third quarter. Pendal Group Ltd now owns 4,414,378 shares of the company’s stock valued at $290,334,000 after buying an additional 910,179 shares during the period. Fiduciary Management Inc. WI boosted its position in Henry Schein by 45.5% during the third quarter. Fiduciary Management Inc. WI now owns 1,913,031 shares of the company’s stock worth $125,820,000 after acquiring an additional 597,877 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale grew its stake in Henry Schein by 55.1% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 1,015,116 shares of the company’s stock worth $67,118,000 after acquiring an additional 360,764 shares during the period. 95.45% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.